Annual Net Income
-$10.01 M
+$7.74 M+43.61%
31 December 2023
Summary:
Akari Therapeutics annual net profit is currently -$10.01 million, with the most recent change of +$7.74 million (+43.61%) on 31 December 2023. During the last 3 years, it has risen by +$7.07 million (+41.41%). AKTX annual net income is now -1382.67% below its all-time high of -$675.00 thousand, reached on 31 December 2010.AKTX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.90 M
+$4.66 M+61.70%
01 September 2024
Summary:
Akari Therapeutics quarterly net profit is currently -$2.90 million, with the most recent change of +$4.66 million (+61.70%) on 01 September 2024. Over the past year, it has dropped by -$24.00 thousand (-0.84%). AKTX quarterly net income is now -144.73% below its all-time high of $6.47 million, reached on 31 December 2015.AKTX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$20.16 M
-$24.00 K-0.12%
01 September 2024
Summary:
Akari Therapeutics TTM net profit is currently -$20.16 million, with the most recent change of -$24.00 thousand (-0.12%) on 01 September 2024. Over the past year, it has dropped by -$14.29 million (-243.39%). AKTX TTM net income is now -1058.45% below its all-time high of -$1.74 million, reached on 31 March 2014.AKTX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKTX Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +43.6% | -0.8% | -243.4% |
3 y3 years | +41.4% | -99.5% | -9.3% |
5 y5 years | +51.2% | -12.8% | -20.2% |
AKTX Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +43.6% | -389.2% | +61.7% | -572.1% | at low |
5 y | 5 years | at high | +51.2% | -389.2% | +62.0% | -572.1% | +5.7% |
alltime | all time | -1382.7% | +77.9% | -144.7% | +94.1% | -1058.5% | +61.9% |
Akari Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$2.90 M(-61.7%) | -$20.16 M(+0.1%) |
June 2024 | - | -$7.56 M(+35.8%) | -$20.13 M(+21.5%) |
Mar 2024 | - | -$5.57 M(+34.5%) | -$16.57 M(+65.6%) |
Dec 2023 | -$10.01 M(-43.6%) | -$4.14 M(+44.1%) | -$10.01 M(+70.5%) |
Sept 2023 | - | -$2.87 M(-28.2%) | -$5.87 M(+95.7%) |
June 2023 | - | -$4.00 M(-499.6%) | -$3.00 M(-35.9%) |
Mar 2023 | - | $1.00 M(-117.6%) | -$4.68 M(-74.1%) |
Dec 2022 | -$17.75 M(+1.9%) | - | - |
June 2022 | - | -$5.68 M(+9.7%) | -$18.10 M(+8.0%) |
Mar 2022 | - | -$5.18 M(-10.6%) | -$16.76 M(-3.8%) |
Dec 2021 | -$17.42 M(+2.0%) | -$5.79 M(+298.8%) | -$17.42 M(-5.5%) |
Sept 2021 | - | -$1.45 M(-66.6%) | -$18.45 M(+14.7%) |
June 2021 | - | -$4.35 M(-25.6%) | -$16.08 M(-16.1%) |
Mar 2021 | - | -$5.84 M(-14.3%) | -$19.17 M(+12.3%) |
Dec 2020 | -$17.08 M(+1.4%) | -$6.81 M(-845.5%) | -$17.08 M(-4.5%) |
Sept 2020 | - | $913.50 K(-112.3%) | -$17.89 M(-16.3%) |
June 2020 | - | -$7.44 M(+98.6%) | -$21.37 M(+18.4%) |
Mar 2020 | - | -$3.75 M(-50.8%) | -$18.05 M(+7.1%) |
Dec 2019 | -$16.85 M(-17.8%) | -$7.62 M(+197.0%) | -$16.85 M(+0.4%) |
Sept 2019 | - | -$2.57 M(-37.7%) | -$16.77 M(-5.8%) |
June 2019 | - | -$4.12 M(+61.8%) | -$17.80 M(-18.0%) |
Mar 2019 | - | -$2.55 M(-66.3%) | -$21.71 M(+5.9%) |
Dec 2018 | -$20.50 M | -$7.55 M(+110.0%) | -$20.50 M(-18.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2018 | - | -$3.59 M(-55.2%) | -$25.07 M(-21.3%) |
June 2018 | - | -$8.02 M(+499.3%) | -$31.86 M(+31.9%) |
Mar 2018 | - | -$1.34 M(-89.0%) | -$24.15 M(-31.8%) |
Dec 2017 | -$35.40 M(+95.1%) | -$12.12 M(+16.8%) | -$35.40 M(+12.1%) |
Sept 2017 | - | -$10.38 M(+3142.7%) | -$31.57 M(+46.1%) |
June 2017 | - | -$320.00 K(-97.5%) | -$21.61 M(-22.1%) |
Mar 2017 | - | -$12.58 M(+51.9%) | -$27.74 M(+52.9%) |
Dec 2016 | -$18.14 M(-60.0%) | -$8.29 M(+1881.8%) | -$18.14 M(+436.3%) |
Sept 2016 | - | -$418.10 K(-93.5%) | -$3.38 M(-93.5%) |
June 2016 | - | -$6.45 M(+116.1%) | -$51.70 M(+11.0%) |
Mar 2016 | - | -$2.99 M(-146.1%) | -$46.59 M(+2.8%) |
Dec 2015 | -$45.32 M(+2226.8%) | $6.47 M(-113.3%) | -$45.30 M(-14.3%) |
Sept 2015 | - | -$48.74 M(+3534.8%) | -$52.89 M(+1109.0%) |
June 2015 | - | -$1.34 M(-21.0%) | -$4.37 M(-16.9%) |
Mar 2015 | - | -$1.70 M(+52.3%) | -$5.26 M(-0.8%) |
Dec 2014 | -$1.95 M(-46.2%) | -$1.11 M(+399.2%) | -$5.31 M(+26.6%) |
Sept 2014 | - | -$223.10 K(-90.0%) | -$4.19 M(+5.6%) |
June 2014 | - | -$2.23 M(+28.1%) | -$3.97 M(+128.1%) |
Mar 2014 | - | -$1.74 M | -$1.74 M |
Dec 2013 | -$3.62 M(-15.2%) | - | - |
Dec 2012 | -$4.27 M(+101.4%) | - | - |
Dec 2011 | -$2.12 M(+213.9%) | - | - |
Dec 2010 | -$675.00 K | - | - |
FAQ
- What is Akari Therapeutics annual net profit?
- What is the all time high annual net income for Akari Therapeutics?
- What is Akari Therapeutics annual net income year-on-year change?
- What is Akari Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Akari Therapeutics?
- What is Akari Therapeutics quarterly net income year-on-year change?
- What is Akari Therapeutics TTM net profit?
- What is the all time high TTM net income for Akari Therapeutics?
- What is Akari Therapeutics TTM net income year-on-year change?
What is Akari Therapeutics annual net profit?
The current annual net income of AKTX is -$10.01 M
What is the all time high annual net income for Akari Therapeutics?
Akari Therapeutics all-time high annual net profit is -$675.00 K
What is Akari Therapeutics annual net income year-on-year change?
Over the past year, AKTX annual net profit has changed by +$7.74 M (+43.61%)
What is Akari Therapeutics quarterly net profit?
The current quarterly net income of AKTX is -$2.90 M
What is the all time high quarterly net income for Akari Therapeutics?
Akari Therapeutics all-time high quarterly net profit is $6.47 M
What is Akari Therapeutics quarterly net income year-on-year change?
Over the past year, AKTX quarterly net profit has changed by -$24.00 K (-0.84%)
What is Akari Therapeutics TTM net profit?
The current TTM net income of AKTX is -$20.16 M
What is the all time high TTM net income for Akari Therapeutics?
Akari Therapeutics all-time high TTM net profit is -$1.74 M
What is Akari Therapeutics TTM net income year-on-year change?
Over the past year, AKTX TTM net profit has changed by -$14.29 M (-243.39%)